Why Safety Signal Management
Has Become So Hard
Signal Management has always been judgment-intensive. But the volume, velocity and variety of safety data feeding
into it have changed beyond recognition.
Four challenges, in particular, are shaping the safety signal detection conversation today.
Signal volumes are rising faster than teams can scale
Adverse event reporting has grown sharply across digital channels and broader product portfolios. Without automation, genuine drug safety signals get lost in the noise.
Plenty of signals, but very few are actionable
Disproportionality analysis surfaces far more signals than any team can evaluate. The harder work is clinical relevance, labelling context, and building a defensible Signal Detection Report.
Manual effort still dominates the signal management workflow
Detection, evaluation, and reporting remain stitched together from spreadsheets and email threads — breeding audit gaps and reviewer fatigue.
The regulatory landscape is moving — and watching closely
GVP Module IX, FDA and EMA expectations, and 21 CFR Part 11 have raised the bar. Teams need a system that keeps pace, not one retrofitted every time guidance evolves.
Signal AI - Automated, Defensible, End-to-End Safety Signal Management
Signal AI is Datafoundry’s purpose-built signal management system for drugs, cosmetics, vaccines, nutraceuticals, food supplements, and medical devices — bringing signal detection and risk management into a single platform that pharmacovigilance teams can run their full workflow on.
Built around product-event combinations, Signal AI automatically generates statistical scores from data ingested across regulatory portals and safety databases, supporting both active and passive surveillance. The result: a faster, more confident path from raw signal to regulatory-grade documentation.
Signal AI is built to flex with your environment. Deploy it as a standalone system or run it alongside Datafoundry’s Safety AI and other industry-leading safety databases so you can modernize drug safety signal detection without disrupting the rest of your pharmacovigilance stack.
What Signal AI
Helps You Do
A modern, cloud-based signal management system that delivers efficiency, accuracy and early risk detection grouped here by the outcomes that matter most to pharmacovigilance teams.
Spot the signals that matter, sooner. Signal AI runs continuous active and passive surveillance on product-event combinations and applies an automated FMEA-based risk analysis that evaluates severity, occurrence and detection in minutes rather than weeks. Instead of drowning in disproportionality output, your team can prioritize the most critical signals and allocate review effort where it changes outcomes.
- Active and passive surveillance with real-time monitoring of product-event combinations
- Automated, multimodal signal detection with composite signal scores
- Automated FMEA-based risk analysis for signal evaluation
- Trend and analytics views based on composite database disproportionality outcomes
Signal AI is built around the regulatory frameworks pharmacovigilance teams are already accountable to and so compliance becomes a property of the workflow, not a separate exercise. GVP Module IX alignment, FDA and EMA relevance, and 21 CFR Part 11 controls are baked in, and a live regulatory intelligence feed keeps your team ahead of the changes that affect them.
- GVP Module IX alignment -
end-to-end process mapped to current EMA expectations - FDA and EMA relevance across signal detection, evaluation and reporting
- 21 CFR Part 11 compliance - electronic records, signatures and audit trail
- Customizable filters for reporting and audit trail
- Regulatory intelligence feed directly on the dashboard
The hard work in safety signal management is judgment and Signal AI gives that judgment better inputs. Customizable clinical risk flags help reviewers cut through noise; built-in QC means every signal report carries an explicit approve/reject decision trail; and signal schedules, notification forms and reports are generated automatically, so the team’s time goes into the decisions, not the formatting.
- Customizable clinical risk flags tuned to your therapeutic area and risk appetite
- Built-in QC feature to approve or reject a signal report with full traceability
- Auto-generated signal schedule, signal notification forms and signal reports
- Interactive UI and advanced analytics designed with input from PV domain experts
Signal AI was built to slot into the safety stack you already have. Out-of-the-box connectors cover the data sources pharmacovigilance teams cannot work without, and language pack configurations support deployment across global markets so the same system serves your headquarters, regional affiliates and CRO partners.
- Connects with MedDRA and WHO-DD, ClinicalTrials.gov and EDC platforms
- Works alongside industry-leading safety platforms, including Datafoundry’s Safety AI
- Language pack configurations available for Japanese, Chinese and more
- Plug-in architecture - deploy standalone or alongside your existing safety database
A user-friendly interface, an end-to-end workflow, and a system architected for regulated pharmacovigilance from the ground up.
Improve the Efficiency of Your Signal Management Process by
Improved productivity and accuracy
Automated, multimodal signal detection with composite signal scores so your team spends less time generating signals and more time evaluating the ones that matter.
Drop-in deployment
Run Signal AI on its own or connect it to any industry-leading safety database, so you can modernize signal management without re-platforming your full PV stack.
Regulated-grade by design
Built to meet applicable regulations and guidance - 21 CFR Part 11, data integrity and privacy controls, and GxP — with the audit trail to prove it.
Built for the people who use it
An intuitive interface shaped by inputs from pharmacovigilance domain experts, so signal management feels less like operating a tool and more like running a process.
How Signal AI Works
A six-step workflow that takes your team from raw safety data to a defensible, regulator-ready Signal Detection Report with most teams up and running on Signal AI within a few weeks of kick-off.
Further Reading on Safety Signal Management
A curated set of perspectives from the Datafoundry team on where signal detection and management in pharmacovigilance is heading, and how AI is reshaping it.
Frequently Asked Questions
